These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11921491)

  • 21. Sulbactam: a beta-lactamase inhibitor.
    Noguchi JK; Gill MA
    Clin Pharm; 1988 Jan; 7(1):37-51. PubMed ID: 3278833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
    Campoli-Richards DM; Brogden RN
    Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramuscular sulbactam/ampicillin combination therapy in gynaecological and obstetric bacterial infections.
    Abbassi AF; Said A; Gaber A
    J Int Med Res; 1991; 19 Suppl 1():44A-49A. PubMed ID: 2060693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients].
    Lode H; Springsklee M
    Med Klin (Munich); 1989 May; 84(5):236-41. PubMed ID: 2661984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections.
    Akova M; Ozcebe O; Güllü I; Unal S; Gür D; Akalin S; Tokgözoglu M; Telatar F; Akalin HE
    J Chemother; 1996 Aug; 8(4):284-9. PubMed ID: 8873834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
    De Simone C; Chiodo F; Delia S; Pastore G; Scalise G; Sorice F; Tonietti G; Zanussi C; Paoloni M; Gargiulo M
    J Chemother; 1991 Oct; 3(5):321-7. PubMed ID: 1809811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An open comparative study of sulbactam/ampicillin vs mezlocillin in adult and pediatric patients. Efficacy and tolerability].
    Chiodo F; Manfredi R; Zucchini A
    Minerva Med; 1991 Jun; 82(6):387-94. PubMed ID: 2067712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of beta-lactam/beta-lactamase inhibitors in the management of mixed infections.
    Akalin HE
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S15-20; discussion S26-7. PubMed ID: 10526869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational antibiotic therapy and the position of ampicillin/sulbactam.
    Lode HM
    Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical study of sultamicillin fine granules].
    Okada K; Kawakami K; Takeda E
    Jpn J Antibiot; 1988 Dec; 41(12):1954-8. PubMed ID: 3249368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetic and clinical studies on sulbactam/ampicillin in the pediatric field].
    Ito M; Ihara T; Kamiya H; Sakurai M; Shimizu S; Nishi H; Kawaguchi H; Yoshizumi T; Inoue M; Kojima M
    Jpn J Antibiot; 1989 Mar; 42(3):651-61. PubMed ID: 2746848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose sultamicillin oral suspension in the treatment of mild to moderate paediatric infections in Turkey.
    Raillard P; Kose G; Ozkan H; Hasanoglu A; Firat S; Feiner C
    J Int Med Res; 1992; 20 Suppl 1():12A-23A. PubMed ID: 1451925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field].
    Nakao Y; Kimura H; Miura K; Miyajima Y; Ishikawa H; Hayakawa F; Kuno K
    Jpn J Antibiot; 1989 Mar; 42(3):639-50. PubMed ID: 2746847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on sulbactam/ampicillin in the field of pediatrics].
    Nakamura H; Miyazu M; Kasai K; Iwai N; Taneda Y
    Jpn J Antibiot; 1989 Mar; 42(3):662-74. PubMed ID: 2664250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of sulbactam-ampicillin/sultamicillin in mixed infections.
    Moosdeen F
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S1. PubMed ID: 10526866
    [No Abstract]   [Full Text] [Related]  

  • 37. Sultamicillin versus trimethoprim/sulfamethoxazole in the treatment of urinary tract infections.
    Naber KG; Wittenberger R
    APMIS Suppl; 1989; 5():57-62. PubMed ID: 2660873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
    Powell LL; Wilson SE
    Surg Infect (Larchmt); 2000; 1(1):57-63. PubMed ID: 12594910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open non-comparative pilot study of the safety and efficacy of oral sultamicillin in the treatment of mild to moderate upper respiratory tract infections in children.
    Argüello A
    J Int Med Res; 1992; 20 Suppl 1():24A-30A. PubMed ID: 1451926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics and clinical effects of sultamicillin fine granules in pediatrics].
    Morita H; Hisakawa H; Okada T; Kawakubo K; Kubota H; Hamada F; Tomoda T; Araki K; Tone Y; Wakiguchi H
    Jpn J Antibiot; 1988 Dec; 41(12):1973-9. PubMed ID: 3249371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.